主页 > 医学信息 >
【medical-news】PET market continues double-digit growth
The demand for PET continued to grow in 2005, reaching 1.2 million procedures, an increase of 24% for the year. Procedure volume should increase 31% in 2006, according to a recent study by market research firm Bio-Tech Systems.
The Las Vegas-based company predicted that by 2012, PET procedure volume should rise to 4.4 million procedures annually. The firm attributed the growth to the approval of new indications in oncology have added to procedure volume, as well as expanded use of PET in lung cancer, breast cancer, colon cancer, lymphoma, and melanoma. Cardiology studies, in particular rubidium PET studies for myocardial perfusion, will contribute to procedure growth, as will neurology studies.
Bio-Tech said that the growth of PET procedures volume has stimulated sales of FDG, while reducing the cost per dose. It said FDG sales of $259 million in 2005 will increase 31% in 2006 to $340 million, and the firm predicts FDG sales will reach $933 million by 2012 on the basis of current utilization trends.
In 2005, there were 326 PET scanners sold in the U.S. and 608 systems worldwide, representing sales of $534.9 million in the U.S. and worldwide sales of $985.5 million; this represents increases of 13% and 15.8%, respectively, over the prior year. The research company noted that U.S. and international users have adopted PET-CT very rapidly, with hybrid systems comprising about 95% of total billings in 2005.
Bio-Tech said it anticipates that by 2012, U.S. bookings will increase to 550 units with sales of $907.5 million, while worldwide bookings will reach 1,095 units and $1.8 billion in sales volume. The proportion of international PET sales will continue to rise, from 45% in 2005 to 50% or higher by 2012, according to the firm. PET market continues double-digit growth
PET市场以两位数的速度发展。
The demand for PET continued to grow in 2005, reaching 1.2 million procedures, an increase of 24% for the year. Procedure volume should increase 31% in 2006, according to a recent study by market research firm Bio-Tech Systems.
根据生物技术系统的市场调研结果：市场对PET的需求持续增高，在2005年达到120万，增长率达到24%。在2006年的增长率可以达到31%。
The Las Vegas-based company predicted that by 2012, PET procedure volume should rise to 4.4 million procedures annually. The firm attributed the growth to the approval of new indications in oncology have added to procedure volume, as well as expanded use of PET in lung cancer, breast cancer, colon cancer, lymphoma, and melanoma. Cardiology studies, in particular rubidium PET studies for myocardial perfusion, will contribute to procedure growth, as will neurology studies.
Las Vegas的这家公司估计，在2012年，PET操作在440万每年。公司认为PET市场增长的原因在于增加了新的肿瘤适应症，并且PET检查已经扩展倒了肺癌，乳腺癌，直肠癌，淋巴瘤和黑色素瘤。心血管研究，尤其是铷PET心肌灌注，会进一步拉动PET市场，并且还有神经研究的发展。
Bio-Tech said that the growth of PET procedures volume has stimulated sales of FDG, while reducing the cost per dose. It said FDG sales of $259 million in 2005 will increase 31% in 2006 to $340 million, and the firm predicts FDG sales will reach $933 million by 2012 on the basis of current utilization trends.
生物技术公司还说，PET应用的增加，刺激了FDG的生产，从而降低了FDG的剂量价格。FDG在2005年的销售业绩是2.59亿，在2006年增加31%，达到3.40亿，根据目前的趋势，公司预测在2012年可以达到9.33亿。
In 2005, there were 326 PET scanners sold in the U.S. and 608 systems worldwide, representing sales of $534.9 million in the U.S. and worldwide sales of $985.5 million; this represents increases of 13% and 15.8%, respectively, over the prior year. The research company noted that U.S. and international users have adopted PET-CT very rapidly, with hybrid systems comprising about 95% of total billings in 2005.
2005年，美国卖出326台PET机器，全球卖出608台，美国销售额5.34亿，世界销售额9.85亿，相对去年分别增长13%和15.8％，公司注意到PET－CT在美国和全世界的应用都非常快，2005卖出的机型95%是PET-CT。
Bio-Tech said it anticipates that by 2012, U.S. bookings will increase to 550 units with sales of $907.5 million, while worldwide bookings will reach 1,095 units and $1.8 billion in sales volume. The proportion of international PET sales will continue to rise, from 45% in 2005 to 50% or higher by 2012, according to the firm.
公司估计到达2002年，美国的订单会达到550，销售额达到9.07亿，世界订单将会达到1095台，销售额达到180亿。世界的PET比重将会持续增加，从2005年的45%，到2006年的50%，2012年会更高。
阅读本文的人还阅读：
作者:admin@医学,生命科学 2010-10-30 05:11
医学,生命科学网